At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized, Phase II Trial of CHOP vs. Oral Chemotherapy With Concomitant Antiretroviral Therapy in Patients With HIV-Associated Lymphoma in Sub-Saharan Africa
In Brief
A Phase 2 clinical trial evaluating cyclophosphamide, doxorubicin hydrochloride, and 6 other interventions for AIDS-related Diffuse Large Cell Lymphoma and 8 related conditions. Completed, enrolled 7 participants across 2 sites in 2 countries.
Detailed Summary
This randomized phase II trial studies how well intravenous (IV) chemotherapy or oral chemotherapy works in treating patients with previously untreated stage III-IV human immunodeficiency virus (HIV)-associated non-Hodgkin lymphoma. Drugs used in chemotherapy, such as cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate, prednisone, lomustine, etoposide, and procarbazine hydrochloride, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells
Study Details
Timeline
Interventions
Given IV
Given IV
Given IV
Given PO
Given PO
Given PO
Given PO
Given PO
Correlative studies